Anti-diabetic drugs containing rosiglitazone restricted

  • Nation Premium
  • Sunday, 26 Sep 2010

PETALING JAYA: The Health Ministry wants doctors to restrict the use of anti-diabetic drugs containing rosiglitazone and stop starting new patients on such drugs over safety concerns

Health Ministry director-general Tan Sri Dr Mohd Ismail Merican said in a statement on Sunday that the European Medicines Agency (EMA) on Thursday suspended the use of anti-diabetic drugs after a review by the Committee for Medical Products for Human Use (CHMP) of data about increased risk of adverse cardiovascular effects of rosiglitazone in anti-diabetic drugs like Avandia, Avandemet and Avaglim.

Article type: metered
User access status: 3
Join our Telegram channel to get our Evening Alerts and breaking news highlights

Next In Nation

Sabbaruddin Chik passes away aged 80 Premium
PAS will only contest one seat in S’wak polls, Beting Maro Premium
Devolution of authority in fisheries a first step to greater autonomy, says Kitingan Premium
Hajiji urged to increase state spending to spur Sabah's recovery Premium
Transport Minister visits Bintulu Port Authority Premium
Malaysia, China agree to maintain peace, stability in South China Sea Premium
Covid-19 Watch: More new cases than recoveries, says Health DG Premium
Prices of basic necessities to stabilise soon, says Agriculture Ministry Premium
Muhyiddin optimistic that PN will be people's choice in GE15 Premium
Cops still waiting for toxicology report on senior citizen’s death Premium

Others Also Read